The toxicity of tobramycin at concentrations released from antibiotic-
impregnated polymethylmethacrylate beads was determined using cultured
embryonic chick tibiae. Because previous results from this laboratory
have shown that osteoblast metabolism is inhibited at low pH and beca
use of the potential for a low local pH in infected bone, the antibiot
ic was tested in medium with pH values from 6.8 to 7.4. Bone metabolis
m was evaluated by measuring the rates of glycolysis (lactate producti
on), protein synthesis ([H-3]proline uptake), and collagen synthesis (
[H-3]proline hydroxylation). Tobramycin at the concentrations released
from the beads (1.0-1.5 mg/ml) contributed to lowering the pH of the
medium. At pH 7.4, the antibiotic produced as much as a 30, 39, and 48
% decrease in glycolysis, protein synthesis, and collagen synthesis, r
espectively. Tibiae exposed to tobramycin for 3 days, followed by 2 da
ys without the antibiotic, showed only a partial recovery from its tox
ic effects. Although tobramycin was relatively less toxic in an acidic
environment, the overall metabolic activity of the bones was poorest
when the tobramycin concentration was high (2.0 mg/ml) and pH was low
(6.8). The results of this study support the following conclusions: (a
) tobramycin at high concentrations is toxic to bone, (b) a combinatio
n of high tobramycin concentration and low pH in the bone microenviron
ment may greatly inhibit bone metabolism and (c) treatment and prevent
ion of osteomyelitis by means of tobramycin-impregnated beads may be a
ugmented by preventing the pH from decreasing in traumatized areas.